Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

964 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Blood pressure and cardiovascular risk: what about cocoa and chocolate?
Grassi D, Desideri G, Ferri C. Grassi D, et al. Arch Biochem Biophys. 2010 Sep 1;501(1):112-5. doi: 10.1016/ Epub 2010 Jun 1. Arch Biochem Biophys. 2010. PMID: 20494650 Review.
Angiotensin II inhibits endothelial cell motility through an AT1-dependent oxidant-sensitive decrement of nitric oxide availability.
Desideri G, Bravi MC, Tucci M, Croce G, Marinucci MC, Santucci A, Alesse E, Ferri C. Desideri G, et al. Arterioscler Thromb Vasc Biol. 2003 Jul 1;23(7):1218-23. doi: 10.1161/01.ATV.0000078521.51319.65. Epub 2003 May 22. Arterioscler Thromb Vasc Biol. 2003. PMID: 12763763
Endothelial cell activation in men with erectile dysfunction without cardiovascular risk factors and overt vascular damage.
Bocchio M, Desideri G, Scarpelli P, Necozione S, Properzi G, Spartera C, Francavilla F, Ferri C, Francavilla S. Bocchio M, et al. J Urol. 2004 Apr;171(4):1601-4. doi: 10.1097/01.ju.0000116325.06572.85. J Urol. 2004. PMID: 15017230
Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons.
Grassi D, Lippi C, Necozione S, Desideri G, Ferri C. Grassi D, et al. Am J Clin Nutr. 2005 Mar;81(3):611-4. doi: 10.1093/ajcn/81.3.611. Am J Clin Nutr. 2005. PMID: 15755830 Clinical Trial.
Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives.
Grassi D, Necozione S, Lippi C, Croce G, Valeri L, Pasqualetti P, Desideri G, Blumberg JB, Ferri C. Grassi D, et al. Hypertension. 2005 Aug;46(2):398-405. doi: 10.1161/01.HYP.0000174990.46027.70. Epub 2005 Jul 18. Hypertension. 2005. PMID: 16027246 Clinical Trial.
Inhibition of phosphodiesterase type 5 with tadalafil is associated to an improved activity of circulating angiogenic cells in men with cardiovascular risk factors and erectile dysfunction.
Bocchio M, Pelliccione F, Passaquale G, Mihalca R, Necozione S, Desideri G, Francavilla F, Ferri C, Francavilla S. Bocchio M, et al. Atherosclerosis. 2008 Jan;196(1):313-319. doi: 10.1016/j.atherosclerosis.2006.09.035. Epub 2006 Dec 5. Atherosclerosis. 2008. PMID: 17150221 Clinical Trial.
Enhanced plasma soluble CD40 ligand levels in essential hypertensive patients with blunted nocturnal blood pressure decrease.
Desideri G, Cipollone F, Valeri L, Grassi D, Necozione S, Croce G, Passacquale G, Garofalo A, Lippi C, Mezzetti A, Ferri C. Desideri G, et al. Am J Hypertens. 2007 Jan;20(1):70-6; discussion 77. doi: 10.1016/j.amjhyper.2006.06.007. Am J Hypertens. 2007. PMID: 17198914
C-reactive protein: interaction with the vascular endothelium and possible role in human atherosclerosis.
Ferri C, Croce G, Cofini V, De Berardinis G, Grassi D, Casale R, Properzi G, Desideri G. Ferri C, et al. Curr Pharm Des. 2007;13(16):1631-45. doi: 10.2174/138161207780831301. Curr Pharm Des. 2007. PMID: 17584094 Review.
C-reactive protein (CRP) is the first acute phase protein that has been described in the literature. It is phylogenetically ancient and - with serum amyloid P - belongs to proteins named as "pentraxin". ...
C-reactive protein (CRP) is the first acute phase protein that has been described in the literature. It is phylogenetically ancient a
Nifedipine improves the migratory ability of circulating endothelial progenitor cells depending on manganese superoxide dismutase upregulation.
Passacquale G, Desideri G, Croce G, Murgo S, Mancarelli MM, Zazzeroni F, Alesse E, Ferri C. Passacquale G, et al. J Hypertens. 2008 Apr;26(4):737-46. doi: 10.1097/HJH.0b013e3282f4d1bd. J Hypertens. 2008. PMID: 18327084
964 results
Jump to page